Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.
暂无分享,去创建一个
Holger Moch | Peter J Wild | Tullio Sulser | Jean-Jacques Patard | Walter Artibani | Francesco Montorsi | Brett Delahunt | B. Delahunt | J. Patard | F. Montorsi | H. Moch | R. Knuechel | C. Stief | P. Wild | V. Ficarra | W. Artibani | T. Sulser | Vincenzo Ficarra | Ruth Knuechel | Christian G Stief
[1] A. Thackray,et al. Parenchymal carcinoma of the kidney. , 1949, British journal of urology.
[2] D. Jacqmin,et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. , 2009, European urology.
[3] Impact of tumor size on the clinical outcomes of patients with Robson Stage I renal cell carcinoma , 1999, Cancer.
[4] P. Karakiewicz,et al. Treatment of metastatic renal cell carcinoma , 2010, Nature Reviews Urology.
[5] B. Delahunt,et al. Histopathologic prognostic indicators for renal cell carcinoma. , 1998, Seminars in diagnostic pathology.
[6] K. Bensalah,et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. , 2007, European urology.
[7] V. Ficarra,et al. Incidental detection beyond pathological factors as prognostic predictor of renal cell carcinoma. , 2003, European urology.
[8] J. Srigley,et al. Current prognostic factors‐renal cell carcinoma , 1997 .
[9] Jacques Tostain,et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. , 2004, The Journal of urology.
[10] J. Mazeron,et al. TNM classification of malignant tumours (5 e dition) , 1998 .
[11] N. Rioux-Leclercq,et al. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. , 2007, The Journal of urology.
[12] B. Delahunt,et al. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma , 2002, Cancer.
[13] Choung-Soo Kim,et al. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. , 2008, The Journal of urology.
[14] L. Kavoussi,et al. Pathological stage does not alter the prognosis for renal lesions determined to be stage T1 by computerized tomography. , 2005, The Journal of urology.
[15] B. Churchill,et al. The results of radical nephrectomy for renal cell carcinoma. , 1968, Transactions of the American Association of Genito-Urinary Surgeons.
[16] A. Novick,et al. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. , 1999, The Journal of urology.
[17] R. Motzer,et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Lam,et al. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma , 2007, BJU international.
[19] J. Cheville,et al. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? , 2005, The Journal of urology.
[20] A. Sagalowsky,et al. Reassessment of the 1997 TNM classification system for renal cell carcinoma , 2003, Cancer.
[21] V. Ficarra,et al. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome. , 2007, European urology.
[22] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[23] B. Delahunt,et al. Classification of renal cell carcinoma , 1997, Cancer.
[24] A. Moinzadeh,et al. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? , 2004, The Journal of urology.
[25] J. Cheville,et al. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. , 2004, The Journal of urology.
[26] V. Margulis,et al. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. , 2007, The Journal of urology.
[27] L. Sobin,et al. The process for continuous improvement of the TNM classification , 2004, Cancer.
[28] Amanjot S. Sethi,et al. Pathologic upstaging after laparoscopic radical nephrectomy. , 2008, Journal of endourology.
[29] Ch. Wittekind,et al. TNM supplement : a commentary on uniform use , 2003 .
[30] C. J. Robson. Radical nephrectomy for renal cell carcinoma. , 1963, The Journal of urology.
[31] J. Cheville,et al. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. , 2005, The Journal of urology.
[32] Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma. , 2004 .
[33] J. Cheville,et al. Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. , 2005, The Journal of urology.
[34] M. Stöckle,et al. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a. , 2005, The Journal of urology.
[35] J. Cheville,et al. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? , 2005, The Journal of urology.
[36] S. Petković. An anatomical classification of renal tumors in the adult as a basis for prognosis. , 1959, The Journal of urology.
[37] A. Novick,et al. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. , 2001, The Journal of urology.
[38] H. Moch,et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma , 2000, Cancer.
[39] K. Bensalah,et al. The changing evolution of renal tumours: a single center experience over a two-decade period. , 2004, European urology.
[40] B. Ljungberg. Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881 , 2009 .
[41] E. Bollito,et al. Reassessing the current TNM lymph node staging for renal cell carcinoma. , 2006, European urology.
[42] J. Cheville,et al. A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma. , 2005, Clinics in laboratory medicine.
[43] J. Cheville,et al. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? , 2005, The Journal of urology.
[44] F. Guillé,et al. Proposal for revision of the TNM classification system for renal cell carcinoma , 2005, Cancer.
[45] S. Jung,et al. Reappraisal of T3N0/NxM0 renal cell carcinoma: significance of extent of fat invasion, renal vein invasion, and adrenal invasion. , 2008, Human pathology.
[46] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[47] S. Bonsib. Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases , 2006, Modern Pathology.
[48] S. Bonsib,et al. Renal sinus involvement in renal cell carcinomas. , 2000, The American journal of surgical pathology.
[49] G. Martignoni,et al. TNM staging system for renal-cell carcinoma: current status and future perspectives. , 2007, The Lancet. Oncology.
[50] V. Ficarra,et al. Neoplasm staging and organ-confined renal cell carcinoma: a systematic review. , 2004, European urology.
[51] S. Pahernik,et al. Prognostic stratification of localized renal cell carcinoma by tumor size. , 2008, The Journal of urology.
[52] R. Flocks,et al. Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more. , 1958, The Journal of urology.
[53] R. Figlin,et al. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. , 2003, The Journal of urology.
[54] M. Blute,et al. Pathologic staging of renal cell carcinoma , 2001, Cancer.
[55] F. Guillé,et al. Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience. , 2007, European urology.
[56] A. Antonelli,et al. Nephron-Sparing Surgery versus Radical Nephrectomy in the Treatment of Intracapsular Renal Cell Carcinoma up to 7 cm , 2008 .
[57] S. Bonsib. Renal veins and venous extension in clear cell renal cell carcinoma , 2007, Modern Pathology.
[58] A. Buzaid,et al. Exploring the role of novel agents in the treatment of renal cell carcinoma. , 2008, Cancer treatment reviews.
[59] R. Figlin,et al. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? , 2004, The Journal of urology.
[60] R. Figlin,et al. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome. , 2001, The Journal of urology.
[61] A. Tizzani,et al. Proposal of an improved prognostic classification for pT3 renal cell carcinoma. , 2008, The Journal of urology.
[62] F. Guillé,et al. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma , 2005, Cancer.
[63] J. Cheville,et al. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy , 2005, Cancer.